The role of artificial intelligence for precision medicine in multiple myeloma

In this video, Alberto Romagnoni, PhD, Owkin, Paris, France, discusses the role of artificial intelligence (AI) and machine learning in multiple myeloma and other hematological malignancies. Dr Romagnoni first highlights the importance of precision medicine in hematological oncology, and further explains how AI can help when working with rich and complex datasets. Dr Romagnoni then discusses a novel approach in AI and machine learning and the possibility of applying this approach to other modalities. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.